Plasma Ghrelin Levels Are Associated with Anorexia but Not Cachexia in Patients with NSCLC

Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials

(2016) Jennifer S Temel et al.   LANCET ONCOLOGY

Anamorelin hydrochloride for the treatment of cancer-anorexia-cachexia in NSCLC

(2015) Hongjie Zhang et al.   EXPERT OPINION ON PHARMACOTHERAPY

The assessment of anorexia in patients with cancer: cut-off values for the FAACT–A/CS and the VAS for appetite

(2015) S. Blauwhoff-Buskermolen et al.   SUPPORTIVE CARE IN CANCER

Therapeutic potential of anamorelin, a novel, oral ghrelin mimetic, in patients with cancer-related cachexia: a multicenter, randomized, double-blind, crossover, pilot study

(2012) José M. Garcia et al.   SUPPORTIVE CARE IN CANCER

Definition and classification of cancer cachexia: an international consensus

(2011) Kenneth Fearon et al.   LANCET ONCOLOGY

Increased serum levels of ghrelin at diagnosis mediate body weight loss in non-small cell lung cancer (NSCLC) patients

(2009) Eleni M. Karapanagiotou et al.   LUNG CANCER

Ghrelin Gene Products and the Regulation of Food Intake and Gut Motility

(2009) C.-Y. Chen et al.   PHARMACOLOGICAL REVIEWS